Sandra Horning, MD

Executive Vice President, Global Development
Chief Medical Officer

Genentech

Sandra Horning, MD

Executive Vice President, Global Development
Chief Medical Officer

Genentech

Biography

Sandra Horning, MD, is Executive Vice President, Head of Global Product Development, and Chief Medical Officer at Roche/Genentech, and previous served as head of Clinical Development for Hematology and Oncology. During her time at the company, Dr. Horning has brought 15 new medicines to patients and tackled some of the world’s toughest diseases, including cancer, multiple sclerosis, influenza, and blindness. Dr. Horning is a tenured professor of medicine at Stanford University School of Medicine, and previously spent 25 years as a practicing oncologist, investigator, and professor before moving to Genentech. A leader in the oncology community, Dr. Horning served as president of ASCO in 2005-2006 and has been chair of the Lymphoma Community of the Eastern Cooperative Oncology Group (ECOG) since 1995.